Unresectable metastatic gastric cancer who received docetaxel, cisplatin and S-1 combination chemotherapy (DCS chemotherapy)
Conditions
Interventions
After inserting the oral endoscope, histological examination of the duodenal mucosa
Sponsors
University of Tokushima Hospital Gastroenterological medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age: 13 to 79 years old Gender: Not specified Inpatient/outpatient: Not specified
Exclusion criteria
Exclusion criteria: 1)Patients with acute abdomen 2)Patients with severe acute inflammation 3)Patients in a very bad general condition 4)Patients with suspected intestinal perforation 5)Patients having severe blood clotting defect 6)Patients with severe hepatic function 7)Patients with severe respiratory diseases or circulatory diseases 8)Gravia and possibly pregnant patients 9)Patients who do not have the capacity or intention to cooperate with the trial procedures 10)Patients, the investigator(or the subinvestigator) considers, inappropriate for entry into the trial 11)Sick or injured persons in life-threatening conditions and from whom consent for their participation in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum diamine oxidase and duodenal histopathology (villous atrophy) | — |
Countries
Japan
Contacts
Public ContactJinsei Miyoshi
Health Biosciences, The University of Tokushima Graduate school Gastroenterology and Oncology
Outcome results
None listed